2273 articles in this topic
French researchers tracked how kidney failure and dialysis speed up immune cell aging, revealing new connections between organ health and longevity.
Small trial tests whether dasatinib plus quercetin can improve brain blood flow and cognition in at-risk older adults.
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
Clinical trial tests whether dasatinib plus quercetin can reduce liver scarring in fatty liver disease patients.
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
Small study tests whether protein blends can help older adults maintain muscle mass and strength through improved protein synthesis.
Six-month trial examines whether metformin treatment can improve telomere length and longevity gene expression in prediabetic individuals.
144-person study explores how rapamycin, amino acids, and resistance exercise combat sarcopenia and muscle wasting in aging adults.
Small trial tests whether leucine supplementation enhances muscle-building effects of resistance exercise in frail elderly women.
FDA-approved transplant drug tested in 70-95 year olds to combat age-related immune decline and improve longevity markers.
Greek researchers investigated whether whey protein can counter inflammation-driven muscle loss in older adults with chronic inflammation.
McMaster study compares whole milk, skim milk, and almond beverage effects on muscle protein synthesis in aging women.
